Aflac Inc offers supplemental health insurance and life insurance in the United States and Japan... Show more
Aflac Incorporated (AFL), a leading provider of supplemental health and life insurance, maintains a robust dividend policy characterized by quarterly payments and consistent growth. The forward annual dividend is $2.44 per share, yielding 2.13% based on recent stock prices, with the most recent quarterly payout of $0.61 per share declared for shareholders of record on February 18, 2026, paid March 2, 2026. This positions AFL as a dividend growth stock rather than a high-yield play, prioritizing sustainable increases over aggressive payouts. With a history of reliable payments, it appeals to investors focused on compounding income through steady appreciation in distributions.
Aflac has demonstrated remarkable dividend discipline, achieving 43 consecutive years of increases as of 2025. Quarterly dividends have risen steadily: from $0.26 per share in 2018 to $0.42 in 2023, $0.50 in 2024 (19% increase), $0.58 in 2025 (16% hike), and $0.61 in early 2026 (5.2% growth). Over the past five years, annualized dividend growth has averaged approximately 14.8%. No cuts have occurred in decades, reflecting a long-term strategy of returning capital to shareholders while funding operations in Japan and the U.S. This consistency bolsters investor confidence in future hikes.
Aflac's dividend sustainability is strong, supported by a trailing payout ratio of 34.02%, meaning only about one-third of earnings (TTM EPS $6.82) funds dividends, leaving ample room for growth and reinvestment. Levered free cash flow of $5.18 billion (TTM) comfortably covers annual dividend obligations, while operating cash flow at $2.56 billion adds further cushion. A debt-to-equity ratio of 42.68% is manageable for an insurer, complemented by a 21.24% profit margin and 13.12% return on equity (ROE). Despite modest near-term EPS growth projections (-3.34% for 2026), historical coverage and capital returns via buybacks ($3.5 billion in 2025) affirm ongoing viability.
In the insurance sector, Aflac's 2.13% forward yield is competitive, aligning closely with peers like MetLife (MET) at around 2.43% and slightly above some multi-line insurers. Compared to Unum Group (UNM) and others in accident and health insurance, AFL's profile stands out for its superior growth streak and lower payout ratio, versus higher yields but potentially less consistency in peers like CNO Financial (CNO). This makes AFL attractive for those prioritizing quality over top yield in the industry.
Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. It efficiently identifies dividend stocks, income-focused investments, trending stocks, breakout candidates, and market opportunities more effectively than manual screening. Explore the AI Screener to enhance your research today.
Aflac Incorporated (AFL) suits dividend growth investors seeking a balance of moderate yield and proven longevity, given its 43-year increase streak and double-digit historical growth rates. Conservative income seekers may appreciate the low 34% payout ratio and strong cash flow coverage, minimizing cut risks even in volatile insurance markets. Long-term holders benefit from share buybacks complementing dividends, enhancing total returns. However, those chasing high yields above 4% might look elsewhere, as AFL's 2.13% falls short, and near-term growth headwinds could temper enthusiasm. Overall, it fits portfolios emphasizing quality compounders over immediate high income, though sector exposures like Japan operations warrant monitoring.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
a provider of supplemental life and health insurance services
Industry LifeHealthInsurance